What is it?
What Mimosa pudica is
2Mimosa pudica L. is a Fabaceae botanical commonly called sensitive plant or touch-me-not plant. It has traditional uses, but the cited review found no clinical trials or quality-control studies establishing safe, effective human use.
Names, aliases and forms
Mechanisms of action
Preclinical and constituent research
3Reviews describe plant constituents including mimosine, tannins, flavonoids, and other compounds, alongside in vitro and animal findings. Plant part, extract method, and concentration vary, and this research does not establish a human supplement benefit.
Potential effects and evidence map
The literature described in recent reviews is traditional, in vitro, and animal research. A 2023 review reported no clinical trials or quality-control studies for Mimosa pudica, so no condition-specific benefit or evidence-based human dose is established.
No human clinical evidence establishes a calming or relaxation effect from Mimosa pudica supplement products.
Typical dosages and timing
No evidence-based human dose is provided because the cited review found no clinical trials or quality-control studies for Mimosa pudica. A milligram amount on an individual product label is not a validated clinical dose.
Timing & effect horizon
Safety, side effects and risk profile
Human clinical dose, safety, timing, and benefit are not established for ordinary Mimosa pudica supplement products.
Do not assume safety in pregnancy or breastfeeding when no human clinical safety or dose data are established.
No Mimosa pudica-specific human interaction evidence is established here; do not assume a supplement is compatible with medicines.
Kew notes that Mimosa pudica contains mimosine and that large doses can be toxic to humans and animals. This does not quantify the risk of a particular commercial product, because plant part, extraction, concentration, and dose may differ.
Interactions and cautions
No Mimosa pudica-specific human interaction study is used here. Product labels and traditional use do not establish compatibility with prescription medicines, so seek advice from the clinician or pharmacist managing those medicines.
Legal and regulatory status
As of 2026, FDA does not approve dietary supplements for safety and effectiveness before marketing. In the United States, a product presented as a dietary supplement cannot rely on unproven disease claims simply because the ingredient has traditional or preclinical research.
Practical buying and quality notes
- There are no active offers currently mapped for this listing. If comparing future products, identify the labelled plant part, extraction method, and any standardisation; do not treat raw gram amounts across unlike products as clinically equivalent.2
FAQ
Can Mimosa pudica clear parasites?
2No human clinical trial evidence is cited to establish that outcome. The cited review describes in vitro and animal research but reports no clinical trials, so a suspected infection needs appropriate clinical assessment.
What is a studied Mimosa pudica dose?
2No evidence-based human dose is established in the cited material. Individual label servings should not be represented as clinically validated dosing.
References
- Royal Botanic Gardens, Kew. Mimosa pudica L., Plants of the World Online.
- Adurosakin OE, et al. Ethnomedicinal uses, phytochemistry, pharmacological activities and toxicological effects of Mimosa pudica: a review. Pharmacological Research - Modern Chinese Medicine. 2023;7:100241.
- Muhammad G, Hussain MA, Jantan I, Bukhari SNA. Mimosa pudica L., a high-value medicinal plant as a source of bioactives for pharmaceuticals. Comprehensive Reviews in Food Science and Food Safety. 2016;15(2):303-315.
- U.S. Food and Drug Administration. FDA 101: Dietary Supplements.